2013 AAPS Annual Meeting and Exposition

Published: 23-Feb-2012

10 - 14 November 2013

Annual meeting & expo

San Antonio, US

The 2013 AAPS Annual Meeting and Exposition is a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. In one place, scientists can meet their peers in all disciplines; discuss the latest research presented at contributed paper poster sessions; discuss projects with current and new suppliers; and enjoy a scientific program focused on the discovery, development, and manufacture of pharmaceutical products and therapies that advance science and technology. The meeting is a rich resource of knowledge about how to advance scientific projects. Attendees include scientists working in drug design, discovery, development, delivery, packaging, scale-up, clinical trials, and regulatory sciences.

Organiser: American Association of Pharmaceutical Scientists (AAPS)

Trending Articles

  1. BIO International Convention Digital 3-6 June, 2024 | Convention | San Diego, US
  2. CPhI North America 7-9 May 2024 | Exhibition | Pennsylvania, US
  3. ASGCT Annual Meeting 2024 7-11 May, 2024 | Meeting | Portland, OR
  4. Lab Innovations 30-31 October 2024 | Exhibition | Birmingham, UK
  5. Chemspec Europe 19-20 June 2024 | Exhibition | Düsseldorf, Germany

You may also like

Manufacturing

Vetter awarded honours in the CDMO leadership awards

The awards programme selects honourees based on CDMO customer evaluations
Manufacturing

Resilient, flexible and forward-thinking: the future of contract manufacturing

As pharma and biotech companies face economic uncertainty and customer demand evolves, the contract development and manufacturing sector is in the midst of a transformation.
Manufacturing

Vetter contributes to commercial launches of eight customer products in 2023

Vetter's portfolio of early and late-stage clinical services advances product development for injectables
Research & Development

Globally operating CDMO committed to strengthening Germany as a research and production location

Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)
Sustainability

Vetter joins Science Based Targets initiative

A leading global CDMO continues to drive its sustainability strategy forward
Regulatory

Vetter Development Service Rankweil successfully completes reinspection

Vetter’s European clinical site receives permanent Manufacturer’s Authorisation
Manufacturing

Vetter looks ahead to further expansions to meet supply chain demand

Vetter, a leading global contract development and manufacturing organisation (CDMO), announces additional investments as part of its long-term dedication to customer partnerships
Subscribe now